| Hester Biosciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524669 |
NSE Symbol : HESTERBIO |
P/E(TTM) : 37.69 |
|
ISIN Demat : INE782E01017 |
Div & Yield% : 0.53 |
EPS(TTM) : 55.10 |
|
Book Value(₹) : 452.80 |
Market Cap(₹Cr) : 1,766.71 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 93.71 | 70.35 | 64.58 | 63.49 | 76.67 | 62.83 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 93.71 | 70.35 | 64.58 | 63.49 | 76.67 | 62.83 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 11.18 | 1.04 | 1.48 | 0.95 | 1.06 | 1.30 |
| Total Income | 104.89 | 71.39 | 66.05 | 64.44 | 77.73 | 64.13 |
| Total Expenditure | 62.25 | 53.64 | 52.70 | 51.08 | 62.97 | 53.81 |
| PBIDT | 42.64 | 17.75 | 13.36 | 13.36 | 14.76 | 10.32 |
| Interest | 4.09 | 0.90 | 1.27 | 0.91 | 1.25 | 1.59 |
| PBDT | 38.55 | 16.85 | 12.08 | 12.45 | 13.51 | 8.73 |
| Depreciation | 3.68 | 2.21 | 2.20 | 2.16 | 2.03 | 2.24 |
| Tax | 7.72 | 2.42 | 2.48 | 1.84 | 3.67 | 1.66 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.76 | 1.55 | 0.19 | 0.61 | -1.82 | 0.39 |
| Reported Profit After Tax | 26.38 | 10.67 | 7.21 | 7.84 | 9.64 | 4.44 |
| Extra-ordinary Items | 5.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 21.09 | 10.67 | 7.21 | 7.84 | 9.64 | 4.44 |
| EPS (Unit Curr.) | 31.01 | 12.54 | 8.48 | 9.21 | 11.33 | 5.22 |
| EPS (Adj) (Unit Curr.) | 31.01 | 12.54 | 8.48 | 9.21 | 11.33 | 5.22 |
| Calculated EPS (Unit Curr.) | 31.01 | 12.54 | 8.47 | 9.21 | 11.33 | 5.22 |
| Calculated EPS (Adj) (Unit Curr.) | 31.01 | 12.54 | 8.47 | 9.21 | 11.33 | 5.22 |
| Calculated EPS (Ann.) (Unit Curr.) | 124.06 | 50.17 | 33.90 | 36.85 | 45.30 | 20.87 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 124.06 | 50.17 | 33.90 | 36.85 | 45.30 | 20.87 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 45.50 | 25.23 | 20.69 | 21.04 | 19.25 | 16.43 |
| PBDTM(%) | 41.14 | 23.95 | 18.71 | 19.61 | 17.62 | 13.89 |
| PATM(%) | 28.15 | 15.17 | 11.16 | 12.35 | 12.57 | 7.07 |
